Member Info for PM2022

Not allowed to say so if you are smart you would buy at these prices. 201 not even priced in.

Easy 150-200% from here imo once that deal is done.

I would say 3 chances to double from here in the short term.
1) Hakkaido evaluation giving us two in SPV
2) Barcelona evaluation giving us 2 or 3 in SPV
3) The big one VAL 201 which takes us up a few 100% from current SP imo

I would say each has about a 50% and more chance of coming good. If we get all then 80p plus in the next 3 months. Excellent risk to reward at this price.

Yeah but if it is we would be 100p. All about risk vs reward. Lots of news due and 201 looks like it will get done soon. We could also have two in SPV by next month. So much potential and anything below 30p without news is cheap atm.

It looks like she said the Hokkaido evaluation news will be released before the December deadline. Also VAL201 she changed her words from shortly to soon to me she never wanted to make it obvious but it should be very close. Regardless hardly any downside here so a strong buy for sure.

Creditable partner???? Now seriously the deal is almost guaranteed as you would not say that unless serious work has been done. Easy double at least imo. Gut feeling says in the next two weeks.

Sounds to me like she is just waiting for them to sign. My what would be the opening price if 201 drops in. They are also helping with 301.

Great presentation.

Well add 201 to the market cap where does that take us. 60,70, 80p with our amazing preclinical strategy. Suzy remains super confident that it will be completed soon.

After a long year a bit of positivity would be good. TNBC all the way but hopefully a positive hint for 201 for all the patient holders as we deserve it.

Looking forward to a big day tomorrow.

Well it's highly unlikely to go down tomorrow so what are the traders going to do. Buy higher. Are they dumb.

We are undervalued this is only going one way. So much potential and lots of news due.

Looks like lots of news in the next 3 months.

1) Results of Hokkaido University. If successful then we have two in SPV and our market cap should be more than double than market cap even without VAL201.

2) VAL201 I would give a very high chance of it being done in the next 3 months. Progress would have been made over the last one year. Phase 2b cancer drug if the deal is done surely adds about 30-40 million to our market cap immediately.

3) New drug is likely to be added into our pipeline soon giving us further potential.

4) VAL 301 update. Lots of work that has been done has been regarding 301 news is due on this. TRx have also helped with the patents.

5) Further ongoing news regarding TNBC. We are already seeing regular updates regarding this so may still get more RNS's over the next few months.

Not much downside here. I think 40-50p should easily be achieved with some of the news that is due.

Don't forget options are at 25-30p and 40p so we should easily get to that level.

A reminder for tonight and to register. Huge upside here and lots of news due. Looking forward to a great presentation.
Dear all,

London South East are delighted to announce Suzy Dilly is presenting at our next LSE webinar on November 8th, along with Poolbeg Pharma, Goldplat and one other miner. It's online and we recommend you get there at 5:55 for a 6 pm-8pm event. Please do register here: https://us02web.zoom.us/webinar/register/2916672226742/WN_sRgNuezCSY-P5xVD0aRpfA

It's not a cure and it's good for the industry. The market for better drugs is huge. It shows the potential we have.

We should get the results of the next evaluation anytime in the next month which should add significant value. Hopefully a 301 update and 201 will get done as well and that would be a great Christmas. Interesting times at these low prices.

Forget the past just because it's taken time doesn't mean it will not get done soon. They should be close.

Two huge opportunities to double or triple before Christmas.

If the second evaluation is successful that means we would have two in SPV so should be at least 30 p without 201. Second chance 201 deal completes. Most likely both will get done so expecting 50 p in the coming weeks. No real downside here.

Plenty of buyers sitting below this price with plenty of news due.

That means the only way is up now.

Metom you can short the stock if you wish. For me it's only going up. Lots of potential buyers 10-13p so for that reason the downside is minimal. Therefore those deramping are wasting time. The only way is up.

The great part of this investment is that we have lots of news due in the next 2/3 months with TNBC news now done for now. Val201 deal, Val301 update, new drug to be taken on, results for evaluation with Hakkaido University all of which is not priced in and further updates regarding TNBC.

I am sure we will get plenty of publicity with the approach we have taken after the news which will be followed by some large buys. In my view those that will be successful in investing here will be the patient and those that judge the assets in a balanced way not just based on Val201 which has taken longer than expected but is still very likely to complete soon.

Still in my view from the current SP 1/2p downside and 50/60p upside over the next few months with far greater chance of upside. I am 95% sure the deal will complete soon as Suzy has checked progress throughout the last months and remains very confident. Even without that a single positive news should move as much higher than the current SP.

Northern why don't you sell out then. All your posts are very negative. If you don't believe in the strategy and don't think 201 will get done then no point being here. Find another stock.

Nobody is disregarding the legacy drugs. Adam simply stated 201 will get done when it gets done and that could be anytime but I am sure he means before any placing. We have sufficient cash for another year by then 201 will get done and we will get more cash from Cenkos if we move to a decent price above 22p. After a year we may have sold one of the drugs in SPV. Things change nothing is risk free but a great risk to reward.

Newbie let me tell you I have been here since the teens and I did 80% of my buying at the start. The price went up later. It fluctuates and is ongoing. Nothing is lost and nothing is gained until one sells but in the long run this is a great investment.

All the scaremongering that is going on so they can buy in cheaper. A few are trading. The smart ones buy here on the cheap and hold and ignore the noise.

The reality is that we are about 5 weeks away from the second evaluation result. Suddenly whilst all the noise is created we could have two in SPV and our market cap should be double what it is just based on that. I think we will get an update for 301 soon as well.

Suzy is confident the deal will be completed. She has seen evidence of progress. Most importantly it should not be allowed to drag on past December unless they are about to complete. Come January we may get mass sellers if the deal has not been done or no progress has been reported to shareholders as we cannot afford another low price placing.

Good for Suzy to plan ahead unlike last time and put pressure on TRX for an update/completion by year end as you risk destroying the company if this goes into next year.

Darkhero you have lots to learn imo. Important that you learn to think for yourself. Lots of people here are not holding and some are but want to buy more cheaper to trade. It's all agenda driven.

Suzy and the board should carry on doing what they are doing. If they can provide a positive update soon that would be welcome but if carrying on with TRX is the best outcome then they should. None of us know any better.